Results 101 to 110 of about 178,635,816 (158)

Current treatments and outlook in adenocarcinoma of the esophagogastric junction: a narrative review. [PDF]

Ann Transl Med, 2022
Cao F, Hu C, Xu ZY, Zhang YQ, Huang L, Chen JH, Qin JJ, Cheng XD.   +7 more
europepmc   +1 more source

Clinicopathological Significance of STAT3 and p-STAT3 among 91 Patients with Adenocarcinoma of the Esophagogastric Junction. [PDF]

Dis Markers, 2022
Ma RJ, Zheng QM, Zhang N, Sun ZG.
europepmc   +1 more source

Mediastinal lymphadenectomy strategy for Siewert II adenocarcinoma of the esophagogastric junction: a retrospective cohort study. [PDF]

World J Surg Oncol
Liu BW, Feng YR, Chen LQ, Hu WP, Bo-Liao, Yang YS, Shang QX.   +6 more
europepmc   +1 more source

Is Proximal Gastrectomy Oncologically Justifiable for Advanced Siewert II/III Adenocarcinoma of the Esophagogastric Junction? [PDF]

J Gastric Cancer
Wang H, Ye Z, Lu Y, Hu H, Jiang Y, Li W, Shao X, Tian Y.   +7 more
europepmc   +1 more source

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction. [PDF]

BMC Cancer, 2023
Kamiya H, Komatsu S, Nishibeppu K, Ohashi T, Konishi H, Shiozaki A, Kubota T, Fujiwara H, Okamoto K, Otsuji E.   +9 more
europepmc   +1 more source

Adenocarcinoma Around the Esophagogastric Junction Mimicking Submucosal Tumors: A Case Report. [PDF]

Cureus
Ueda R, Oura S, Kataoka N.
europepmc   +1 more source

Prognostic Value of Intraoperative Blood Transfusion in Patients with Adenocarcinoma of the Esophagogastric Junction. [PDF]

Medicina (Kaunas), 2022
Nakajima K, Tokunaga M, Okuno K, Saito K, Fujiwara N, Sato Y, Hoshino A, Matsuyama T, Kinugasa Y.   +8 more
europepmc   +1 more source

Efficacy of distal perigastric lymphadenectomy for Siewert type II adenocarcinoma of the esophagogastric junction. [PDF]

Front Surg
Li Z, Liu Y, Jiang Y, Song M.
europepmc   +1 more source

Selection of two intrathoracic anastomosis methods for transabdominal radical surgery for Siewert type II adenocarcinoma of the esophagogastric junction. [PDF]

Wideochir Inne Tech Maloinwazyjne, 2023
Huang Y, Liu G, Zhang Y, Zhao Z, Yang K, Cao Z, Li J, Zhang C.   +7 more
europepmc   +1 more source

Outcomes of Microscopic Residual Tumor after Curative-Intent Surgery in Adenocarcinoma of Esophagogastric Junction

Siriraj Medical Journal
Objective: Radical surgery is the mainstay treatment for adenocarcinoma of the esophagogastric junction. The presence of microscopic residual tumor tissue after curative-intent surgery is associated with recurrence.
Chawisa Nampoolsuksan, Khajohnsak Bhocksombud, Thammawat Parakonthun, Tharathorn Suwatthanarak, Thikhamporn Tawantanakorn, Nicha Srisuworanan, Voraboot Taweerutchana, Atthaphorn Trakarnsanga, Chainarong Phalanusitthepha, Jirawat Swangsri, Thawatchai Akaraviputh, Asada Methasate, Vitoon Chinswangwatanakul   +12 more
doaj